Target intelligence / Profile preview

Outer membrane protein C (OmpC) (OmpC)

Target
OmpC
Molecular classification
Porin, Outer membrane protein, Beta-barrel protein, Transporter
01

Overview

Outer membrane protein C (OmpC) is a major porin found in the outer membrane of Gram-negative bacteria, such as Escherichia coli and Salmonella species. It forms a trimeric beta-barrel structure that functions as a non-specific aqueous channel, allowing the passive diffusion of small hydrophilic molecules, including essential nutrients and various classes of antibiotics like beta-lactams and fluoroquinolones (UniProt P06996). OmpC expression is tightly regulated by environmental osmolarity via the EnvZ/OmpR two-component system, typically increasing in high-osmolarity conditions to maintain cellular homeostasis (PubMed: 25233374). In the context of infectious diseases, OmpC is a critical determinant of antibiotic susceptibility; mutations, reduced expression, or porin switching are frequently associated with the development of multi-drug resistance in clinical isolates (PubMed: 28439033). Furthermore, OmpC serves as a significant antigen in the human immune response, where the presence of anti-OmpC antibodies is utilized as a diagnostic biomarker for inflammatory bowel diseases, specifically helping to differentiate Crohn's disease from ulcerative colitis (PubMed: 11246362).

Other names
Porin COuter membrane porin COmpC porinOmp2
02

Mechanism of action

OmpC acts as a passive diffusion channel that facilitates the entry of hydrophilic antibiotics into the periplasmic space of Gram-negative bacteria. While not typically inhibited by drugs, its presence and pore size determine the intracellular concentration and efficacy of various antimicrobial agents.

03

Biological functions

Passive transportOsmoregulationNutrient uptakeWaste excretionStructural integrity
04

Disease associations

InfectionInflammatory bowel diseaseCrohn's diseaseAntimicrobial resistance
05

Safety considerations

Downregulation or mutation leads to multi-drug resistance (MDR)Alterations in porin expression can compensate for fitness costs in resistant strainsCross-reactivity of anti-OmpC antibodies with host tissues in autoimmune contexts
06

Interacting drugs

Meropenem

5 more in the full profile.

07

Biomarkers

Anti-OmpC antibodiesOmpC expression levels (for antibiotic resistance profiling)

Beyond the preview

Go deeper on Outer membrane protein C (OmpC) (OmpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer membrane protein C (OmpC) (OmpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call